EndoSemio's AI-powered ENT endoscope fuses narrow-band and white light imaging to highlight vascular changes linked to early nasopharyngeal cancer. Using a CNN+LSTM AI model trained on a large clinical database, it enables rapid, real-time identification of high-risk lesions—bringing advanced cancer screening to ENT clinics and reducing diagnostic delays.

EndoSemio is a medtech startup developing imaging platform across single-use micro endoscopes. Our solutions enable early cancer detection and real-time diagnostics across ENT, neonatal, urology, and veterinary applications. Co-founded by experienced clinicians and engineers, recognized by SelectUSA and Taiwan's National Innovation Award, we aim to make advanced medical imaging more accessible and practical for frontline healthcare professionals.